|Bid||52.52 x 900|
|Ask||52.54 x 800|
|Day's range||52.18 - 52.94|
|52-week range||45.33 - 59.00|
|Beta (5Y monthly)||0.24|
|PE ratio (TTM)||25.68|
|Earnings date||01 Nov 2021 - 05 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||58.56|
Faster-than-expected vaccination uptake leads to a reduction in demand for COVID-19 testing for QIAGEN (QGEN) in Q2.
Qiagen (QGEN) delivered earnings and revenue surprises of 1.52% and 0.88%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
VENLO, the Netherlands, July 29, 2021--QIAGEN reports full results for Q2 and H1 2021